cystic fibrosi affect 30,000 peopl
u.s. fatal inherit disord clog airway
thick mucous caus respiratori digest
problem
orphan-drug status qualifi owner patent
exclus market right seven year subject fda
approv owner new drug applic genzym
develop r-cftr neozym corp. research
develop compani genzym form 1989
